
Lecithin–cholesterol acyltransferase - Wikipedia
Lecithin–cholesterol acyltransferase (LCAT, also called phosphatidylcholine–sterol O-acyltransferase) is an enzyme found in many animals, including humans. It converts free cholesterol into cholesteryl ester, a more hydrophobic form of cholesterol.
LCAT gene - MedlinePlus
The LCAT gene provides instructions for making an enzyme called lecithin-cholesterol acyltransferase (LCAT). This enzyme plays a role in removing cholesterol from the blood and tissues.
Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic ...
Lecithin cholesterol acyltransferase (LCAT) (EC2.3.1.43), a lipoprotein-associated enzyme, is a key player in the reverse cholesterol transport (RCT) pathway, which promotes the transfer of excess cellular cholesterol from peripheral tissues to the liver for excretion [1].
Lecithin-Cholesterol Acyltransferase - ScienceDirect Topics
Lecithin cholesterol acyltransferase (LCAT) is the key enzyme in mediating the esterification of cholesterol on circulating lipoproteins. It has long been suggested that LCAT plays a crucial role in reverse cholesterol transport, a process depicting the removal of cellular cholesterol through efflux to high density lipoproteins (HDL) and its ...
Familial lecithin-cholesterol acyltransferase (LCAT) deficiency; a ...
Phosphatidylcholine-sterol O-acyltransferase is another name for LCAT; an enzyme bound to both HDL and LDL in plasma. This enzyme is responsible for the conversion of free cholesterol into cholesterol ester which renders it more hydrophobic ( 3 ).
LCAT- targeted therapies: Progress, failures and future
Mar 1, 2022 · Lecithin: cholesterol acyltransferase (LCAT) is the sole enzyme which can maintain the free cholesterol (FCh) gradient (homeostasis) between peripheral tissues and high-density lipoprotein (HDL) through esterifying FCh and loading it into HDL particles.
Lecithin:cholesterol acyltransferase: symposium on 50 years of ...
LCAT converts free cholesterol to cholesteryl esters in the process of reverse cholesterol transport. Familial LCAT deficiency (FLD) is a genetic disease that was first described by Kaare R. Norum and Egil Gjone in 1967.
Lecithin cholesterol acyltransferase - ScienceDirect
Dec 15, 2000 · LCAT is a soluble enzyme that converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lyso-phosphatidylcholines on the surface of high-density lipoproteins.
LCAT Enzyme Replacement Therapy Reduces LpX and Improves …
Jul 5, 2018 · Lecithin:cholesterol acyltransferase (LCAT) (EC2.3.1.43) is the only plasma enzyme capable of catalyzing cholesteryl ester (CE) formation from free cholesterol (FC) and phosphatidylcholine (lecithin).
Lecithin cholesterol acyltransferase - PubMed
Dec 15, 2000 · LCAT is a soluble enzyme that converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lyso-phosphatidylcholines on the surface of high-density lipoproteins.